Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Sep 23;60(10):5627-30.
doi: 10.1128/AAC.00705-16. Print 2016 Oct.

Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis

Jocelyn Y Ang  1 , Nahed Abdel-Haq  2 , Frank Zhu  2 , Abrar K Thabit  3 , David P Nicolau  4 , Michael J Satlin  5 , David van Duin  6
Affiliations
Case Reports

Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis

Jocelyn Y Ang et al. Antimicrob Agents Chemother. .

Abstract

We describe a pediatric cystic fibrosis patient who developed a pulmonary exacerbation due to two multidrug-resistant (MDR) Pseudomonas aeruginosa isolates. In addition to these MDR organisms, the case was further complicated by β-lactam allergy. Despite the MDR phenotype, both isolates were susceptible to an antimicrobial combination.

PubMed Disclaimer

References

    1. Merck & Co., Inc. 2015. Product information: Zerbaxa intravenous injection, ceftolozane/tazobactam intravenous injection. Merck & Co., Inc., Whitehouse Station, NJ.
    1. Ambrose PG, Bhavnani SM, Rubino CM, Louie A, Gumbo T, Forrest A, Drusano GL. 2007. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore. Clin Infect Dis 44:79–86. doi: 10.1086/510079. - DOI - PubMed
    1. Kuti JL, Pettit RS, Neu N, Cies JJ, Lapin C, Muhlebach MS, Novak KJ, Nguyen ST, Saiman L, Nicolau DP. 2015. Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis. Diagn Microbiol Infect Dis 83:53–55. doi: 10.1016/j.diagmicrobio.2015.04.012. - DOI - PubMed
    1. Lepak AJ, Reda A, Marchillo K, Van Hecker J, Craig WA, Andes D. 2014. Impact of MIC range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the ceftolozane in vivo pharmacokinetic/pharmacodynamic target. Antimicrob Agents Chemother 58:6311–6314. doi: 10.1128/AAC.03572-14. - DOI - PMC - PubMed
    1. Hong MC, Hsu DI, Bounthavong M. 2013. Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and beta-lactamase-inhibitor combination. Infect Drug Resist 6:215–223. doi: 10.2147/IDR.S36140. - DOI - PMC - PubMed

Publication types

MeSH terms